Human Papillomavirus (HPV) self-testing among un- and under-screened Māori, Pasifika, and Asian women in Aotearoa New Zealand: a preference survey among responders and interviews with clinical-trial non-responders
Authors:
- Susan Mary ShermanSSSusan Mary Sherman
- Karen BartholomewKBKaren Bartholomew
- Naomi BrewerNBNaomi Brewer
- Collette BromheadCollette Bromhead
- Sue CrengleSCSue Crengle
- Jeroen DouwesJDJeroen Douwes
- Sunia FoliakiSFSunia Foliaki
- Jane GrantJGJane Grant
- Georgina McPhersonGMGeorgina McPherson
- John D. PotterJPJohn D. Potter
Preprint
Abstract
Aim: Māori, Pasifika, and Asian women are less likely to attend cervical screening and Māori and Pasifika women are more likely to be diagnosed with later-stage cervical cancer than other women in Aotearoa New Zealand. This study – with under-screened women taking part in a randomised controlled trial comparing self-testing and standard screening – explored the acceptability of an HPV self-test kit and the preferred method for receiving it. Methods: Māori, Pasifika, and Asian women (N=376) completed a postal questionnaire. Twenty-six women who had not accepted the trial invitation were interviewed to understand their reasons for non-participation. Results: Most women found the self-test kit easy and convenient to use and reported that they did not find it painful, uncomfortable, or embarrassing. This was reflected in the preference for a self-test over a future smear test on the same grounds. Most women preferred to receive the kit by mail and take the test themselves, rather than having it done by a doctor or nurse. There was a range of preferences relating to how to return the kit. Phone calls with non-responders revealed that, although most had received the test kit, the reasons for not choosing to be involved included not wanting to, being too busy, or forgetting. Conclusions: HPV self-testing was acceptable for Māori, Pasifika, and Asian women in Aotearoa New Zealand. HPV self-testing has considerable potential to reduce the inequities in the current screening programme and should be made available with appropriate delivery options as soon as possible.Keywords
All Related Versions
- Published version: Health Expectations, 25 (6), 2914.
This publication has 11 references indexed in Scilit:
- Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility StudyInternational Journal of Environmental Research and Public Health, 2021
- Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New ZealandThe Lancet Regional Health - Western Pacific, 2021
- A Māori and Pasifika Label—An Old History, New ContextGenealogy, 2021
- Achieving cervical cancer elimination among Indigenous womenPreventive Medicine, 2021
- Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling?Cancer Epidemiology, Biomarkers & Prevention, 2021
- Reaching under‐screened/never‐screened indigenous peoples with human papilloma virus self‐testing: A community‐based cluster randomised controlled trialAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2020
- HPV Self-sampling in Indigenous Communities: A Scoping ReviewJournal of Immigrant and Minority Health, 2019
- Acceptability of self‐taken vaginal HPV sample for cervical screening among an under‐screened Indigenous populationAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2019
- A community laboratory drop-off option for bowel screening test kits increases participation rates: results from an interrupted time series analysisJournal of Public Health, 2017
- Women’s experience with home-based self-sampling for human papillomavirus testingBMC Cancer, 2015